Format

Send to

Choose Destination
Sultan Qaboos Univ Med J. 2014 Feb;14(1):e13-25. Epub 2014 Jan 27.

The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

Author information

1
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;
2
Antimicrobial Resistance Research Center, Faculty of Medicine, Iran University of Medical Science, Tehran, Iran;
3
Cellular & Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran;
4
Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran.

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). The major pathological outcomes of the disease are the loss of blood-brain barrier (BBB) integrity and the development of reactive astrogliosis and MS plaque. For the disease to occur, the non-resident cells must enter into the immune-privileged CNS through a breach in the relatively impermeable BBB. It has been demonstrated that matrix metalloproteinases (MMPs) play an important role in the immunopathogenesis of MS, in part through the disruption of the BBB and the recruitment of inflammatory cells into the CNS. Moreover, MMPs can also enhance the cleavage of myelin basic protein (MBP) and the demyelination process. Regarding the growing data on the roles of MMPs and their tissue inhibitors (TIMPs) in the pathogenesis of MS, this review discusses the role of different types of MMPs, including MMP-2, -3, -7, -9, -12 and -25, in the immunopathogenesis and treatment of MS.

KEYWORDS:

Blood-Brain Barrier; Central Nervous System; Inflammation; Matrix Metalloproteinases; Multiple Sclerosis

PMID:
24516744
PMCID:
PMC3916267

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center